Additional Cervical Cancer Testing
GenPath utilizes the most advanced Pap Test technology with capabilities in both the Hologic ThinPrep Imaging System with Dual Review and the BD FocalPoint™ Slide Profiler Intelligent Pap Imaging™. Our ASCUS rate, ASCUS:LSIL ratio, and AGC rates rank among the best when compared to industry standards, giving you confidence in the accuracy of our results.
HPV Plus is an in-vitro test for the detection of Human papillomavirus in cytological specimens. The test utilizes amplification of target DNA by the Polymerase Chain Reaction (PCR) based on dual priming oligonucleotide technology and detects all HPV strains epidemiologically classified by the IARC (International Agency for Research on Cancer) as high risk types associated with cervical cancer. Additionally, it specifically identifies if the high risk type detected is either HPV 16 or HPV 18; two strains that are considered to be the most oncogenic types.
Our experienced board-certified medical experts handle even the most challenging cases. Our pathologists employ the most current adjunctive tools, including p16ink4a and Ki67, in conjunction with traditional technologies, to provide the most accurate diagnosis. Consultative services with our staff are available for your convenience.